05.21.13
Executive Relocates From Italy to Serve as K2M’s New Executive VP of Global Sales
Leesburg, Va.-based K2M Inc. has promoted Gianluca Iasci to the position of executive vice president of global sales effective immediately. He will continue to report to Eric Major, president and CEO of the company.
In his new role, Iasci will be responsible for K2M’s global distribution and expansion efforts in both the United States and international markets. He previously acted as K2M’s senior vice president of international sales.
“I am confident that Gianluca’s international view of the world will provide strong leadership to our global mission of delivering leading technologies to surgeons and patients,” said Major. “His hands-on customer centric management style and emphasis on performance accountability will help us continue to achieve rapid growth, as he brings the same degree of strategy and execution discipline to his management of the U.S. market.”
Prior to joining K2M, Iasci served as senior vice president of international at AGA Medical and served for 12 years with Johnson & Johnson in various European sales and marketing positions. He also was the managing director of Italy while at Guidant (now Boston Scientific) and spent four years at St. Jude Medical Inc., where he was stationed in Hong Kong, China, gaining experience in the Asia-Pacific market.
“Since joining K2M, Gianluca has been instrumental in establishing and expanding direct sales operations in the UK, Germany, Switzerland, Austria, Italy and Scandinavia, as well as our business in Spain, Australia, New Zealand, Japan and the Middle East,” continued Major. “The global alignment of our sales organization under Gianluca in this new, unified role is an important milestone in K2M’s strategic plan to become the worldwide leader in complex spine and minimally invasive technologies.”
Iasci and his family will be relocating to Leesburg from Rome, Italy.
K2M is a spinal device company focusing on complex spinal pathologies and minimally invasive procedures. Recently, the company expanded its U.S. biologics offering by adding a new bone putty to its Vesuvius Osteobiologic Systems line and launched Venado foam strips and Venadogranules bone graft systems. In December, K2M launched Mesa spinal systems and Serengeti minimally invasive retractor systems in Italy.
Leesburg, Va.-based K2M Inc. has promoted Gianluca Iasci to the position of executive vice president of global sales effective immediately. He will continue to report to Eric Major, president and CEO of the company.
Iasci |
“I am confident that Gianluca’s international view of the world will provide strong leadership to our global mission of delivering leading technologies to surgeons and patients,” said Major. “His hands-on customer centric management style and emphasis on performance accountability will help us continue to achieve rapid growth, as he brings the same degree of strategy and execution discipline to his management of the U.S. market.”
Prior to joining K2M, Iasci served as senior vice president of international at AGA Medical and served for 12 years with Johnson & Johnson in various European sales and marketing positions. He also was the managing director of Italy while at Guidant (now Boston Scientific) and spent four years at St. Jude Medical Inc., where he was stationed in Hong Kong, China, gaining experience in the Asia-Pacific market.
“Since joining K2M, Gianluca has been instrumental in establishing and expanding direct sales operations in the UK, Germany, Switzerland, Austria, Italy and Scandinavia, as well as our business in Spain, Australia, New Zealand, Japan and the Middle East,” continued Major. “The global alignment of our sales organization under Gianluca in this new, unified role is an important milestone in K2M’s strategic plan to become the worldwide leader in complex spine and minimally invasive technologies.”
Iasci and his family will be relocating to Leesburg from Rome, Italy.
K2M is a spinal device company focusing on complex spinal pathologies and minimally invasive procedures. Recently, the company expanded its U.S. biologics offering by adding a new bone putty to its Vesuvius Osteobiologic Systems line and launched Venado foam strips and Venadogranules bone graft systems. In December, K2M launched Mesa spinal systems and Serengeti minimally invasive retractor systems in Italy.